Raphael Pharmaceutical Inc.
RAPH· OTC
RAPHRaphael Pharmaceutical Inc.
Filed Nov 16, 2021 · 10-Q · 47 days after period end · 0001213900-21-059980
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Net Income | -$416.00K | -$243.00K |
| EPS Diluted | $0.03 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Raphael Pharmaceutical Inc. · CIK 1415397 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 16, 2021 · 47 d after period end
